Use of Scrambler Therapy in Acute Paediatric Pain: A Case Report and Review of the Literature

We report our clinical experience on the effect of Scrambler Therapy (ST) for a child with acute mixed pain refractory to pharmacological treatment. ST, recently proposed as an alternative treatment for chronic neuropathic pain in adults, is a noninvasive approach to relieve pain, by changing pain perception at brain level. It is safe and has no side effects. Further research is needed to assess its efficacy for acute pain and for paediatric population.

[1]  P. Notaro,et al.  Pilot evaluation of scrambler therapy for pain induced by bone and visceral metastases and refractory to standard therapies , 2016, Supportive Care in Cancer.

[2]  C. Compagnone,et al.  Chronic pain treatment and scrambler therapy: a multicenter retrospective analysis. , 2015, Acta bio-medica : Atenei Parmensis.

[3]  Steven P. Cohen,et al.  Predictive Factors Associated With Success and Failure for Calmare (Scrambler) Therapy: A Multicenter Analysis , 2015, The Clinical journal of pain.

[4]  A. Starkweather,et al.  Decreased low back pain intensity and differential gene expression following Calmare®: results from a double-blinded randomized sham-controlled study. , 2015, Research in nursing & health.

[5]  C. Loprinzi,et al.  Therapeutic Strategies for Cancer Treatment Related Peripheral Neuropathies , 2014, Current Treatment Options in Oncology.

[6]  Steven P. Cohen,et al.  Neuropathic pain: mechanisms and their clinical implications , 2014, BMJ : British Medical Journal.

[7]  Thomas J. Smith,et al.  A Trial of Scrambler Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy , 2013, Journal of pain & palliative care pharmacotherapy.

[8]  Y. Ko,et al.  Clinical Experiences on the Effect of Scrambler Therapy for Patients with Postherpetic Neuralgia , 2013, The Korean journal of pain.

[9]  J. Moon,et al.  Scrambler Therapy for Patients with Cancer Pain - Case Series - , 2013, The Korean journal of pain.

[10]  M. Maltoni,et al.  Managing chronic pain: results from an open-label study using MC5-A Calmare® device , 2012, Supportive Care in Cancer.

[11]  S. Kumar,et al.  Prospective study of application of biological communication (cybernatics) in management of chronic low back pain--a preliminary report. , 2011, Nepal Medical College journal : NMCJ.

[12]  Thomas J. Smith,et al.  Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy. , 2010, Journal of Pain and Symptom Management.

[13]  R. Baron,et al.  painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain , 2006, Current medical research and opinion.

[14]  M. Mccaffery,et al.  Pain: Clinical Manual for Nursing Practice , 1989 .

[15]  D. Harrison,et al.  Pain prevalence in a pediatric hospital: raising awareness during Pain Awareness Week. , 2014, Pain research & management.

[16]  Thomas J. Smith,et al.  Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy , 2014, Supportive Care in Cancer.

[17]  Thomas J. Smith,et al.  Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial. , 2012, Journal of Pain and Symptom Management.

[18]  A. Sabato,et al.  Scrambler therapy. , 2005, Minerva anestesiologica.

[19]  G. Marineo.  Untreatable pain resulting from abdominal cancer: new hope from biophysics? , 2003, JOP : Journal of the pancreas.

[20]  D. Fallon,et al.  A simple and versatile fear-conditioning chamber requiring no shock scrambler. , 1970, Physiology & behavior.